147 related articles for article (PubMed ID: 8762873)
1. Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients.
Vera-Sempere FJ; Burgos JS; Botella MS; Cordoba J; Gobernado M
Eur J Cancer B Oral Oncol; 1996 May; 32B(3):163-8. PubMed ID: 8762873
[TBL] [Abstract][Full Text] [Related]
2. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
Pathmanathan R; Prasad U; Chandrika G; Sadler R; Flynn K; Raab-Traub N
Am J Pathol; 1995 Jun; 146(6):1355-67. PubMed ID: 7778675
[TBL] [Abstract][Full Text] [Related]
3. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel.
Bar-Sela G; Kuten A; Minkov I; Gov-Ari E; Ben-Izhak O
J Clin Pathol; 2004 Mar; 57(3):290-3. PubMed ID: 14990602
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
[TBL] [Abstract][Full Text] [Related]
6. Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients.
Plaza G; Santón A; Vidal AM; Bellas C
Acta Otolaryngol; 2003 Jun; 123(5):664-8. PubMed ID: 12875592
[TBL] [Abstract][Full Text] [Related]
7. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
[TBL] [Abstract][Full Text] [Related]
8. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
9. Association of Epstein-Barr virus and nasopharyngeal carcinoma in Caucasian patients.
Plaza G; Manzanal AI; Fogué L; Santón A; Martínez-Montero JC; Bellas C
Ann Otol Rhinol Laryngol; 2002 Mar; 111(3 Pt 1):210-6. PubMed ID: 11913680
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
11. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
Burgos JS; Vera-Sempere FJ
Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of Ebstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinoma.
Ozyar E; Ayhan A; Korcum AF; Atahan IL
Cancer Invest; 2004; 22(4):483-91. PubMed ID: 15565804
[TBL] [Abstract][Full Text] [Related]
13. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
Brousset P; Butet V; Chittal S; Selves J; Delsol G
Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
[TBL] [Abstract][Full Text] [Related]
16. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of EBER1 in nontumor nasopharyngeal biopsies and nontumor component of nasopharyngeal carcinoma.
Chen CL; Hsu MM; Hsu HC
Intervirology; 1996; 39(4):230-5. PubMed ID: 9078463
[TBL] [Abstract][Full Text] [Related]
18. Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR.
Takeuchi H; Kobayashi R; Hasegawa M; Hirai K
Arch Virol; 1997; 142(9):1743-56. PubMed ID: 9672634
[TBL] [Abstract][Full Text] [Related]
19. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
